Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study

被引:0
作者
Miroslava Hejdova
Vladimir Palicka
Zdenek Kucera
Jiri Vlcek
机构
[1] Charles University in Prague,Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove
[2] Charles University,Osteocentre, University Hospital
来源
Pharmacy World and Science | 2005年 / 27卷
关键词
Alendronate; Bone mineral density; Calcitonin; Czech Republic; Observational study; Postmenopausal osteoporosis;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: Alendronate and calcitonin are antiresorptive drugs that were used for the treatment of postmenopausal osteoporosis and were shown to increase bone mineral density (BMD). However, the effect of both drugs in daily clinical practice may differ from that observed in clinical trials.
引用
收藏
页码:149 / 153
页数:4
相关论文
共 90 条
[31]  
Emkey R(undefined)undefined undefined undefined undefined-undefined
[32]  
Rodriguez-Portales JA(undefined)undefined undefined undefined undefined-undefined
[33]  
Menkens CA(undefined)undefined undefined undefined undefined-undefined
[34]  
Wasnich RD.(undefined)undefined undefined undefined undefined-undefined
[35]  
Fairney A(undefined)undefined undefined undefined undefined-undefined
[36]  
Kyd P(undefined)undefined undefined undefined undefined-undefined
[37]  
Thomas E(undefined)undefined undefined undefined undefined-undefined
[38]  
Wilson J.(undefined)undefined undefined undefined undefined-undefined
[39]  
Pols HAP(undefined)undefined undefined undefined undefined-undefined
[40]  
Felsenberg D(undefined)undefined undefined undefined undefined-undefined